IPP Bureau
DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce
By IPP Bureau - April 15, 2026
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables
By IPP Bureau - April 15, 2026
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Microbot Medical begins full US market release of LIBERTY endovascular robotic system
By IPP Bureau - April 15, 2026
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Bisleri expands CSR support for rural mental health programme in MP
By IPP Bureau - April 15, 2026
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
By IPP Bureau - April 15, 2026
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Nihon Kohden launches Life Scope E7 patient monitoring platform in India
By IPP Bureau - April 15, 2026
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
MedLern partners with Godrej Memorial Hospital to strengthen accreditation-led workforce training
By IPP Bureau - April 15, 2026
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi
By IPP Bureau - April 15, 2026
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
CDSCO invites bids for next-gen Digital Drugs Regulatory System
By IPP Bureau - April 15, 2026
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
By IPP Bureau - April 15, 2026
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
FDA presses 2,200+ companies to fix missing clinical trial results
By IPP Bureau - April 15, 2026
Move amid evidence of widespread reporting gaps
Pinky Promise opens first physical clinic in Mumbai, expands women’s hybrid healthcare model
By IPP Bureau - April 15, 2026
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab
By IPP Bureau - April 14, 2026
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations
By IPP Bureau - April 14, 2026
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
